Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression

Papachristodoulou, A., Heidegger, I., Virk, R. K., Di Bernardo, M., Kim, J. Y., Laplaca, C., Picech, F., Schäfer, G., De Castro, G. J., Hibshoosh, H., Loda, M., Klocker, H., Rubin, M. A., Zheng, T., Benson, M. C., McKiernan, J. M., Dutta, A., & Abate-Shen, C. (2024). Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. European Urology, 85(4), 361–372. https://doi.org/10.1016/j.eururo.2023.07.016
Authors:
Alexandros Papachristodoulou
Isabel Heidegger
Renu K Virk
Matteo Di Bernardo
Jaime Y Kim
Caroline Laplaca
Florencia Picech
Georg Schäfer
Guarionex Joel De Castro
Hanina Hibshoosh
Massimo Loda
Helmut Klocker
Mark A Rubin
Tian Zheng
Mitchell C Benson
James M McKiernan
Aditya Dutta
Cory Abate-Shen
Affiliated Authors:
Alexandros Papachristodoulou
Renu K Virk
Matteo Di Bernardo
Jaime Y Kim
Caroline Laplaca
Florencia Picech
Guarionex Joel De Castro
Hanina Hibshoosh
Tian Zheng
Mitchell C Benson
James M McKiernan
Aditya Dutta
Cory Abate-Shen
Subjects:
Author Keywords:
nkx3.1
metformin
prostate cancer
precision medicine
mitochondria
oxidative stress
Publication Type:
Article
Unique ID:
10.1016/j.eururo.2023.07.016
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: